Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period?

Published:2018-12-18 Issue:1 Volume:69 Page:51-63
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Jain Mamta K.¹²,Thamer Mae³,Therapondos George⁴^ORCID,Shiffman Mitchell L.⁵,Kshirsagar Onkar³,Clark Christopher²,Wong Robert J.⁶^ORCID

Affiliation:

1. Division of Infectious Diseases; University of Texas Southwestern Medical Center; Dallas TX

2. Parkland Health and Hospital System; Dallas TX

3. Medical Technology and Practice Patterns Institute; Bethesda MD

4. Multi-Organ Transplant Institute, Ochsner Health System; New Orleans LA

5. Liver Institute of Virginia, Bon Secours Health System; Richmond VA

6. Division of Gastroenterology & Hepatology; Alameda Health System - Highland Hospital; Oakland CA

Funder

Gilead Sciences

American Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.30171/fullpdf

Reference44 articles.

1. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

2. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection;Sulkowski;N Engl J Med,2014

3. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis;Poordad;N Engl J Med,2014

4. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection;Feld;N Engl J Med,2015

5. Grazoprevir-elbasvir combination therapy for treatment-naive cirrhotic and noncirrhotic patients with chronic HCV genotype 1, 4, or 6 infection: a randomized trial;Zeuzem;Ann Intern Med,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective study of hepatitis C screening and seroprevalence in the GHU Paris;L'Encéphale;2024-09

2. Micro‐elimination of chronic hepatitis C virus in mental health settings: A prospective multicentre pragmatic trial;Drug and Alcohol Review;2024-05-21

3. Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014–2020;AJPM Focus;2024-04

4. Birth cohort‐specific consideration in an Emergency Department Hepatitis C Testing Programme: A description of age‐related characteristics and outcomes;Journal of Viral Hepatitis;2024-02-17

5. Low risk of viral hepatitis amongst patients with severe mental disorders;Liver International;2023-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3